Amalgamated Bank’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Amalgamated Bank’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,965	Closed	-$825K	–	3053
2023 Q2	$825K	Buy	20,965 +1,760	+9%	+$62.1K	0.01%	1204
2023 Q1	$467K	Sell	19,205 -3,231	-14%	-$70.7K	﹤0.01%	1452
2022 Q4	$480K	Buy	22,436 +3,262	+17%	+$69.6K	﹤0.01%	1486
2022 Q3	$344K	Buy	19,174 +812	+4%	+$10.7K	﹤0.01%	1603
2022 Q2	$177K	Buy	18,362 +3,500	+24%	+$43.9K	﹤0.01%	1929
2022 Q1	$250K	Sell	14,862 -1,063	-7%	-$15.7K	﹤0.01%	1850
2021 Q4	$266K	Buy	15,925 +1,327	+9%	+$21.8K	﹤0.01%	1874
2021 Q3	$237K	Buy	14,598 +997	+7%	+$10.8K	﹤0.01%	1931
2021 Q2	$86K	Buy	+13,601	New	+$87.7K	﹤0.01%	2127

Amalgamated Bank's ISEE Position: Q3 2023 in Review

Amalgamated Bank sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 20,965 shares — an estimated $825K sold.

Amalgamated Bank first reported a position in ISEE in Q2 2021 and held it in 9 quarters. The position peaked at $825K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Amalgamated Bank reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Amalgamated Bank sold 20,965 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $825K.
Amalgamated Bank first reported a position in IVERIC bio, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
Amalgamated Bank's IVERIC bio, Inc. Common Stock position peaked at $825K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Amalgamated Bank's 13F filing for Q3 2023, filed 8 Nov 2023.